Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic drug monitoring (TDM) measures specific drug levels in a patient's blood to optimize therapy and tailor treatment. TDM is critical for managing drugs with narrow therapeutic indices, like digoxin and phenytoin, ensuring they are both safe and effective. For example, monitoring theophylline levels in asthma patients enables precise dose adjustments based on individual responses, enhancing efficacy while preventing toxicity.

Drug analysis methods include LC–MS (high-pressure liquid chromatography with mass spectrometry), colorimetry, spectrophotometry, and immunoassays. The choice of method depends on the drug's physicochemical properties, desired concentration levels, biological specimen type, and laboratory resources. These techniques are selected to ensure reliable measurement of drug levels that accurately reflect patient exposure.

Precision and accuracy are essential qualities in TDM tests. Precision ensures drug levels are consistently measured, while accuracy ensures measurements are correct and reflect true patient exposure. Together, they guarantee that measured drug concentrations reliably represent actual drug levels in the patient's body, supporting effective therapeutic decision-making and appropriate dose adjustments.

Sensitivity assessment defines the minimum detectable drug level, establishing the lower monitoring limit for TDM. This ensures laboratories can reliably detect drugs at clinically relevant concentrations. Knowing the sensitivity limit helps clinicians determine whether measured levels are accurate and whether dose adjustments are needed to achieve therapeutic targets.

Dynamic range and linearity assessments evaluate an instrument's response to varying drug concentrations, ensuring accurate quantification across clinically relevant levels. These tests confirm that as drug doses change, measured blood levels respond proportionally and predictably. This validation is critical for determining whether dose adjustments will produce expected changes in patient drug exposure.

Stability testing confirms that drug concentrations remain unchanged during storage and handling, which is crucial for maintaining consistent dosing and reliable TDM results. If drug samples degrade during storage, measured levels may not reflect true patient exposure, leading to incorrect dose adjustments. Validated stability ensures that samples collected and stored for analysis provide accurate therapeutic information.

Bioavailability studies assess drug absorption and systemic availability to guide appropriate dosing schedules. While not part of TDM itself, these studies provide essential information about how much drug reaches the bloodstream after administration. Understanding bioavailability helps clinicians select optimal doses and administration routes, ensuring that therapeutic drug monitoring data translates into effective patient treatment.